| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |